Healthcare -
Biotechnology - NASDAQ - US
$ 19.07
-7.43 %
$ 3.24 B
Market Cap
-7.28
P/E
IMVT - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities IMVT - Immunovant, Inc.
472 M
LAST VALUE
53.64%
2 YEAR CAGR
67.73%
5 YEAR CAGR
0.00%
10 YEAR CAGR